# Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

> **NCT03775629** · PHASE1 · COMPLETED · sponsor: **CrystalGenomics, Inc.** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Polmacoxib and Tramadol combination
- **DRUG:** Polmacoxib
- **DRUG:** Tramadol hydrochloride

## Key facts

- **NCT ID:** NCT03775629
- **Lead sponsor:** CrystalGenomics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2019-04-04
- **Final completion:** 2019-04-10
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03775629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03775629, "Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03775629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*